You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
Title |
Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC-4): a multicentre, open-label, randomised, phase 3 trial
|
---|---|
Published in |
The Lancet, January 2017
|
DOI | 10.1016/s0140-6736(16)32409-6 |
Pubmed ID | |
Authors |
John P Neoptolemos, Daniel H Palmer, Paula Ghaneh, Eftychia E Psarelli, Juan W Valle, Christopher M Halloran, Olusola Faluyi, Derek A O'Reilly, David Cunningham, Jonathan Wadsley, Suzanne Darby, Tim Meyer, Roopinder Gillmore, Alan Anthoney, Pehr Lind, Bengt Glimelius, Stephen Falk, Jakob R Izbicki, Gary William Middleton, Sebastian Cummins, Paul J Ross, Harpreet Wasan, Alec McDonald, Tom Crosby, Yuk Ting, Kinnari Patel, David Sherriff, Rubin Soomal, David Borg, Sharmila Sothi, Pascal Hammel, Thilo Hackert, Richard Jackson, Markus W Büchler, European Study Group for Pancreatic Cancer |
X Demographics
The data shown below were collected from the profiles of 186 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
United Kingdom | 30 | 16% |
United States | 29 | 16% |
Spain | 8 | 4% |
Canada | 6 | 3% |
India | 4 | 2% |
Australia | 4 | 2% |
Germany | 3 | 2% |
Mexico | 3 | 2% |
United Arab Emirates | 2 | 1% |
Other | 26 | 14% |
Unknown | 71 | 38% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 110 | 59% |
Practitioners (doctors, other healthcare professionals) | 39 | 21% |
Scientists | 31 | 17% |
Science communicators (journalists, bloggers, editors) | 6 | 3% |
Mendeley readers
The data shown below were compiled from readership statistics for 910 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Germany | 2 | <1% |
United Kingdom | 2 | <1% |
Czechia | 2 | <1% |
Brazil | 1 | <1% |
Spain | 1 | <1% |
United States | 1 | <1% |
Unknown | 901 | 99% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 125 | 14% |
Student > Ph. D. Student | 100 | 11% |
Other | 98 | 11% |
Student > Bachelor | 82 | 9% |
Student > Doctoral Student | 76 | 8% |
Other | 169 | 19% |
Unknown | 260 | 29% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 400 | 44% |
Biochemistry, Genetics and Molecular Biology | 74 | 8% |
Agricultural and Biological Sciences | 37 | 4% |
Pharmacology, Toxicology and Pharmaceutical Science | 20 | 2% |
Nursing and Health Professions | 19 | 2% |
Other | 62 | 7% |
Unknown | 298 | 33% |
Attention Score in Context
This research output has an Altmetric Attention Score of 583. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 21 February 2024.
All research outputs
#41,397
of 26,007,325 outputs
Outputs from The Lancet
#815
of 43,261 outputs
Outputs of similar age
#893
of 426,535 outputs
Outputs of similar age from The Lancet
#15
of 460 outputs
Altmetric has tracked 26,007,325 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 43,261 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 68.2. This one has done particularly well, scoring higher than 98% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 426,535 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 460 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 96% of its contemporaries.